David M. Mott

6.4k citations

42 papers · 5.2k indexed · 2 hit papers · h-index 23

Impact in

Endocrinology, Diabetes and Metabolism top 0.5%
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Management and Research
- Diabetes Treatment and Management
Physiology top 1%
- Adipose Tissue and Metabolism
- Diet and metabolism studies

Papers in

Endocrinology, Diabetes and Metabolism 11
- Diabetes, Cardiovascular Risks, and Lipoproteins 7
- Diabetes Management and Research 5
Biochemistry 4

Co-authors: Clifton Bogardus Richard E. Pratley Christian Weyer Peter H. Bennett William C. Knowler Stephen Lillioja Maximilian Spraul Éric Ravussin
Journals: Diabetes (8 papers)Metabolism (6 papers)The Journal of Clinical Endocrinology & Metabolism (6 papers)Biochemical and Biophysical Research Communications (5 papers)New England Journal of Medicine (4 papers)
Partner nations: United States Poland Japan

In The Last Decade

David M. Mott

42 papers receiving 4.9k citations

Hit Papers

align trajectories log scale

The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus 1999 · 1.5k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

1999 Journal of Clinical Investigation
1993 New England Journal of Medicine

Peers

Countries citing papers authored by David M. Mott

Since Specialization

Citations

This map shows the geographic impact of David M. Mott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Mott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Mott more than expected).

Fields of papers citing papers by David M. Mott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David M. Mott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Mott. The network helps show where David M. Mott may publish in the future.

Co-authorship network

The 25 scholars most cited alongside David M. Mott, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David M. Mott Line = papers co-authored together David M. Mott links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance Journal of Clinical Investigation ·Leslie J. Baier, Paskasari A. Permana, Xiaolin Yang, Richard E. Pratley, Robert L. Hanson, Gong-Qing Shen, David M. Mott, William C. Knowler, Nancy J. Cox, Yukio Horikawa, Naohisa Oda, Graeme I. Bell, Clifton Bogardus	2000	233
2	The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus Journal of Clinical Investigation ·Christian Weyer, Clifton Bogardus, David M. Mott, Richard E. Pratley Hit paper breakdown →	1999	1462
3	Genetic Analysis of Human Type 1 Protein Phosphatase Inhibitor 2 in Insulin-Resistant Pima Indians Genomics ·Paskasari A. Permana, David M. Mott	1997	7
4	Insulin Resistance and Insulin Secretory Dysfunction as Precursors of Non-Insulin-Dependent Diabetes Mellitus: Prospective Studies of Pima Indians New England Journal of Medicine ·Stephen Lillioja, David M. Mott, Maximilian Spraul, R Ferraro, James E. Foley, Éric Ravussin, William C. Knowler, Peter H. Bennett, Clifton Bogardus Hit paper breakdown →	1993	1212
5	Amylin activates glycogen phosphorylase in the isolated soleus muscle of the rat FEBS Letters ·Andrew A. Young, David M. Mott, Karen Stone, Garth J. S. Cooper	1991	56
6	Insulin-Sensitive Tyrosine Kinase Activity Changes in Parallel with Plasma Insulin and Glucose Concentrations in Humans* The Journal of Clinical Endocrinology & Metabolism ·B. L. Grégoire Nyomba, Boyd Swinburn, Victoria Ossowski, Nilly Epstein Shilo, Clifton Bogardus, David M. Mott	1991	5
7	Skeletal muscle glycogen synthase activity in subjects with non-insulin-dependent diabetes mellitus after glyburide therapy Metabolism ·B. L. Grégoire Nyomba, D. Freymond, Itamar Raz, Karen Stone, David M. Mott, Clifton Bogardus	1990	12
8	Insulin and Hypertension: Relationship to Obesity and Glucose Intolerance in Pima Indians Diabetes ·Mohammed Saad, William C. Knowler, David J. Pettitt, Robert G. Nelson, David M. Mott, Peter H. Bennett	1990	78
9	Adenosine 3′,5′-Monophosphate-Dependent Protein Kinase Activity Decreases in Human Muscle after Insulin Infusion The Journal of Clinical Endocrinology & Metabolism ·Masamichi Okubo, C. Bogardus, Stephen Lillioja, David M. Mott	1989	10
10	Distribution of In Vivo Insulin Action in Pima Indians as Mixture of Three Normal Distributions Diabetes ·Clifton Bogardus, Stephen Lillioja, B. L. Grégoire Nyomba, F. Zurlo, Boyd Swinburn, A Esposito-Del Puente, William C. Knowler, Éric Ravussin, David M. Mott, Peter H. Bennett	1989	89
11	Increased Rate of Cori Cycle in Obese Subjects With NIDDM and Effect of Weight Reduction Diabetes ·J Zawadzki, Robert R. Wolfe, David M. Mott, Stephen Lillioja, Barbara V. Howard, Clifton Bogardus	1988	68
12	Impaired Glucose Tolerance as a Disorder of Insulin Action New England Journal of Medicine ·Stephen Lillioja, David M. Mott, Barbara V. Howard, Peter H. Bennett, Hannele Yki‐Järvinen, D. Freymond, B. L. Grégoire Nyomba, F. Zurlo, Boyd Swinburn, Clifton Bogardus	1988	464
13	The Natural History of Impaired Glucose Tolerance in the Pima Indians New England Journal of Medicine ·Mohammed Saad, William C. Knowler, David J. Pettitt, Robert G. Nelson, David M. Mott, Peter H. Bennett	1988	352
14	The effects of short-term overfeeding on adipocyte metabolism in pima Indians Metabolism ·Atsunori Kashiwagi, David M. Mott, Clifton Bogardus, Stephen Lillioja, Gerald M. Reaven, James E. Foley	1985	37
15	Sodium-potassium pump in cultured fibroblasts from obese donors; No evidence for an inherent decrease of basal or insulin-stimulated activity Metabolism ·I Klimeś, Barbara V. Howard, David M. Mott	1984	10
16	Cell culture studies of a patient with congenital lipoatrophic diabetes—Normal insulin binding with alterations in intracellular glucose metabolism and insulin action Metabolism ·Barbara V. Howard, David M. Mott, Hideki Hidaka, Rose M. Fields, Harvey L. Katzeff, Wm. James Howard, Peter H. Bennett	1981	16
17	Increased Insulin Resistance in Obese, Glucose-Intolerant Southwestern American Indians: Evidence for a Defect Not Explained by Obesity* The Journal of Clinical Endocrinology & Metabolism ·M. Nagulesparan, Peter J. Savage, David M. Mott, Ginger C. Johnson, Roger H. Unger, Peter H. Bennett	1980	21
18	Development of Lithogenic Bile during Puberty in Pima Indians New England Journal of Medicine ·Lynn J. Bennion, William C. Knowler, David M. Mott, Maryam Ehteramian, Peter H. Bennett	1979	48
19	The content of the principal protein target of a hepatic carcinogen in liver tumors. PubMed ·David M. Mott, Brahma P. Sani, Sam Sorof	1973	5
20	Detection of the principal protein target of a hepatic carcinogen Biochemical and Biophysical Research Communications ·Brahma P. Sani, David M. Mott, Shigejiro Inoue, Sam Sorof	1972	5

About David M. Mott

David M. Mott is a scholar working on Endocrinology, Diabetes and Metabolism, Biochemistry, Cell Biology, Molecular Biology and Physiology, having authored 42 papers that have together received 5.2k indexed citations. Recurring topics across this work include Metabolism, Diabetes, and Cancer (16 papers), Pancreatic function and diabetes (8 papers), Adipose Tissue and Metabolism (7 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers), Muscle metabolism and nutrition (6 papers), Diabetes Management and Research (5 papers), Liver Disease Diagnosis and Treatment (5 papers) and Diabetes and associated disorders (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (2.5k citations), Physiology (1.5k citations), Endocrine and Autonomic Systems (273 citations), Surgery (1.4k citations) and Cell Biology (515 citations). David M. Mott has collaborated with scholars based in United States, Poland and Japan. Frequent co-authors include Clifton Bogardus, Richard E. Pratley, Christian Weyer, Peter H. Bennett, William C. Knowler, Stephen Lillioja, Maximilian Spraul, Éric Ravussin, James E. Foley and R Ferraro. Their work appears in journals such as Diabetes, Metabolism, The Journal of Clinical Endocrinology & Metabolism, Biochemical and Biophysical Research Communications and New England Journal of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact